A role for finasteride in the prevention of prostate cancer?
作者信息
LeFevre Michael
出版信息
N Engl J Med. 2013 Aug 15;369(7):670-1. doi: 10.1056/NEJMe1307059.
PMID:23944306
Abstract
摘要
相似文献
1
A role for finasteride in the prevention of prostate cancer?非那雄胺在前列腺癌预防中的作用？
N Engl J Med. 2013 Aug 15;369(7):670-1. doi: 10.1056/NEJMe1307059.
2
Prostate cancer prevention with 5 alpha-reductase inhibitors.使用5α-还原酶抑制剂预防前列腺癌。
Recent Results Cancer Res. 2011;188:109-14. doi: 10.1007/978-3-642-10858-7_9.
3
Few physicians prescribe 5-alpha reductase inhibitors for prostate cancer prevention.很少有医生会开5-α还原酶抑制剂来预防前列腺癌。
CA Cancer J Clin. 2011 Jan-Feb;61(1):1-2. doi: 10.3322/caac.20100. Epub 2011 Jan 3.
4
Survival in the prostate cancer prevention trial.前列腺癌预防试验中的生存率。
N Engl J Med. 2013 Nov 14;369(20):1967. doi: 10.1056/NEJMc1311498.
5
Survival in the prostate cancer prevention trial.前列腺癌预防试验中的生存率。
N Engl J Med. 2013 Nov 14;369(20):1967. doi: 10.1056/NEJMc1311498.
6
Re: long-term survival of participants in the Prostate Cancer Prevention Trial.关于：前列腺癌预防试验参与者的长期生存情况
J Urol. 2014 Feb;191(2):358. doi: 10.1016/j.juro.2013.11.010. Epub 2013 Nov 11.
7
Re: long-term survival of participants in the Prostate Cancer Prevention Trial.关于：前列腺癌预防试验参与者的长期生存情况
J Urol. 2014 Feb;191(2):359. doi: 10.1016/j.juro.2013.11.012. Epub 2013 Nov 14.
8
Re: long-term survival of participants in the Prostate Cancer Prevention Trial.关于：前列腺癌预防试验参与者的长期生存情况
J Urol. 2014 Feb;191(2):359. doi: 10.1016/j.juro.2013.11.011. Epub 2013 Nov 14.
9
Prostate cancer: mortality unaffected by finasteride treatment.前列腺癌：非那雄胺治疗对死亡率无影响。
Nat Rev Urol. 2013 Oct;10(10):551. doi: 10.1038/nrurol.2013.203. Epub 2013 Sep 10.
10
[Prevention of prostate cancer. Long-term results of the Prostate Cancer Prevention Trial (PCPT)].[前列腺癌的预防。前列腺癌预防试验（PCPT）的长期结果]
Internist (Berl). 2014 Aug;55(8):981-2. doi: 10.1007/s00108-014-3544-4.
引用本文的文献
1
How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss.在为男性型脱发开具非那雄胺处方时如何处理生育、恶性肿瘤及非那雄胺后综合征等问题。
Skin Appendage Disord. 2022 May;8(3):245-248. doi: 10.1159/000520493. Epub 2022 Jan 10.
2
The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality.使用5α还原酶抑制剂治疗良性前列腺增生症及全因死亡风险
Urology. 2018 Sep;119:70-78. doi: 10.1016/j.urology.2018.05.033. Epub 2018 Jun 12.
3
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia.5-α还原酶抑制剂与接受良性前列腺增生治疗男性的前列腺癌死亡风险
Mayo Clin Proc. 2016 Dec;91(12):1717-1726. doi: 10.1016/j.mayocp.2016.07.023. Epub 2016 Oct 27.
Zotero 插件